Pompe Disease

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

Pompe Disease Registry Protocol

AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease

Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

A Global Prospective Observational Registry of Patients With Pompe Disease

Cognitive and Neurological Pathologies in Pompe Disease

Avalglucosidase Alfa Pregnancy Study

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

Developing a Management Approach for Patients With "Late-Onset" Pompe Disease

Expanded Access for ATB200/AT2221 for the Treatment of Pompe Disease

Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.

Baby Detect : Genomic Newborn Screening

Drug-drug Interaction Study

MSOT in Pompe Disease

A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease

Pompe Lactation Sub-Registry